Peptides & GLP-1

A trusted partner delivering end-to-end solutions from R&D to production and quality control, accelerating your pharmaceutical and biopharmaceutical applications

Focused on the peptide drug and GLP-1 receptor agonist R&D and manufacturing track, we systematically present customized chromatography purification media and full-process workflow solutions for this field. Our solutions are designed to help pharmaceutical companies improve product purity and yield, reduce production costs, and accelerate the clinical filing and commercialization of innovative GLP-1 drugs.

Application Description

01

Exceptional Column Lifetime of Nearly 900 Injections with UniSil^® Revo Silica Media

With competition in the GLP-1 field intensifying, active pharmaceutical ingredient (API) prices continue to decline. To maintain profitability, manufacturers must optimize costs along the entire process chain. Downstream purification is a major contributor to production cost, and chromatography media, the core consumable of the purification step, is the primary target for cost control. There are two main paths to reducing media costs: extending media lifetime through process optimization, and lowering the unit cost of media through alternative sourcing and large-volume purchasing.